memantine hydrochloride
PolandDrugs containing this active substance
-
The medicine is used in the treatment of patients with moderate to severe Alzheimer's disease. It helps to improve memory and the transmission of nerve impulses in the brain.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 10 mg ATC: N06DX01
Manufacturer: APL Swift Services (Malta) Ltd. Generis Farmaceutica, S.A.
-
The medicine is used for the treatment of patients with moderate to severe Alzheimer's disease. It helps to improve nerve impulse transmission and memory.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 20 mg ATC: N06DX01
Manufacturer: APL Swift Services (Malta) Ltd. Generis Farmaceutica, S.A.
-
The medicine is used to treat patients with moderate to severe Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 10 mg ATC: N06DX01
Manufacturer: Biofarm Sp. z o.o.
-
The medicine is used for the treatment of patients with moderate to severe Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 160 mg ATC: N06DX01
Manufacturer: Biofarm Sp. z o.o.
-
The medicinal product is used in the treatment of patients with moderate to severe Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 10 mg ATC: N06DX01
Manufacturer: S.C. Zentiva S.A., Zentiva, spol. s r.o.
-
The medicinal product is used for the treatment of patients with moderate to severe Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 20 mg ATC: N06DX01
Manufacturer: S.C. Zentiva S.A., Zentiva, spol. s r.o.
-
The medicine is intended for the treatment of patients with moderate to severe Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 20 mg ATC: N06DX01
Manufacturer: Laboratorios Lesvi S.L. neuraxpharm Arzneimittel GmbH
-
The medicine is used for the treatment of patients with moderate to severe Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 10 mg ATC: N06DX01
Manufacturer: Laboratorios Lesvi S.L. neuraxpharm Arzneimittel GmbH
-
The medicine is used to treat patients with moderate to severe Alzheimer's disease. It helps to improve nerve impulse transmission and memory.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 10 mg ATC: N06DX01
Manufacturer: Glenmark Pharmaceuticals s.r.o.
-
The medicine is used to treat patients with moderate to severe Alzheimer's disease. It helps to improve nerve impulse transmission and memory.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 20 mg ATC: N06DX01
Manufacturer: Glenmark Pharmaceuticals s.r.o.
-
The medicine is used to treat patients with moderate to severe Alzheimer's disease. It helps to alleviate dementia symptoms.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 10 mg ATC: N06DX01
Manufacturer: AS Grindeks
-
The medicinal product is used for the treatment of adult patients with moderate to severe Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 10 mg ATC: N06DX01
Manufacturer: Orion Corporation
-
The medicine is used in adult patients with moderate to severe Alzheimer's disease. It helps to improve nerve impulse transmission and memory.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 20 mg ATC: N06DX01
Manufacturer: Orion Corporation
-
The medicine is used to treat patients with moderate to severe Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 10 mg ATC: N06DX01
Manufacturer: Genericon Pharma Gesellschaft m.b.H. Industria Quimica y Farmaceutica VIR S.A. Synthon B.V. Synthon Hispania S.L. Vipharm S.A.
-
The medicine is used in the treatment of patients with moderate to severe Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 20 mg ATC: N06DX01
Manufacturer: Genericon Pharma Gesellschaft m.b.H. Industria Quimica y Farmaceutica VIR S.A. Synthon B.V. Synthon Hispania S.L. Vipharm S.A.
-
The medicine is used to treat patients with moderate to severe Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 10 mg ATC: N06DX01
Manufacturer: Egis Pharmaceuticals PLC, HBM Pharma s.r.o.
-
The medicinal product is used in the treatment of patients with moderate to severe Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 10 mg ATC: N06DX01
Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.
-
The medicine is intended for the treatment of patients with moderate to severe Alzheimer's disease. It helps to improve nerve impulse transmission and memory.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 20 mg ATC: N06DX01
Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.
-
The medicine is used to treat patients with moderate to severe Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 10 mg ATC: N06DX01
Manufacturer: Gedeon Richter Polska Sp. z o.o.
-
The medicine is used for the treatment of patients with moderate to severe Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 10 mg ATC: N06DX01
Manufacturer: G.L. Pharma GmbH
-
The medicine is used in the treatment of patients with moderate to severe Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 20 mg ATC: N06DX01
Manufacturer: G.L. Pharma GmbH
-
The medicine is used to treat patients with moderate to severe Alzheimer's disease.
Form: solution, oral
Active substance Dosage memantine hydrochloride 5 mg ATC: N06DX01
Manufacturer: Medana Pharma S.A.
-
The medicine is used to treat patients with moderate to severe Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 10 mg ATC: N06DX01
Manufacturer: Polpharma Pharmaceutical Works S.A.
-
The medicine is used to treat patients with moderate to severe Alzheimer's disease.
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 20 mg ATC: N06DX01
Manufacturer: Polpharma Pharmaceutical Works S.A.
-
The medicine is used to treat patients with moderate to severe Alzheimer's disease.
Form: tablets, dispersible in the oral cavity
Active substance Dosage memantine hydrochloride 10 mg ATC: N06DX01
Manufacturer: Genepharm S.A. Rontis Hellas Medical and Pharmaceutical Products S.A.
-
Zenmem is used for the treatment of patients with moderate to severe Alzheimer's disease.
Form: tablets, dispersible in the oral cavity
Active substance Dosage memantine hydrochloride 20 mg ATC: N06DX01
Manufacturer: Genepharm S.A. Rontis Hellas Medical and Pharmaceutical Products S.A.